| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | GDC-0941 | GDSC1000 | pan-cancer | AAC | -0.018 | 0.6 |
| mRNA | narciclasine | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | vincristine | CTRPv2 | pan-cancer | AAC | -0.016 | 0.6 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | MLN4924 | GDSC1000 | pan-cancer | AAC | 0.021 | 0.6 |
| mRNA | alisertib:navitoclax (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | QW-BI-011 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.6 |
| mRNA | Tamoxifen | GDSC1000 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | ABT-263 | CTRPv2 | pan-cancer | AAC | -0.017 | 0.6 |
| mRNA | AZD-2281 | FIMM | pan-cancer | AAC | 0.081 | 0.6 |